☰

Amy C. Yan, Ph.D. - Publications

Affiliations: 
2008 Biochemistry University of Texas at Austin, Austin, Texas, U.S.A. 
Area:
Molecular Biology, Pharmacology
Tree Info Grants Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Requena MD, Yan A, Llanga T, Sullenger BA. Reversible Aptamer Staining, Sorting, and Cleaning of Cells (Clean Fluorescent Activated Cell Sorting) with Antidote Oligonucleotide or Nuclease Yields Fully Responsive Cells. Nucleic Acid Therapeutics. PMID 38285522 DOI: 10.1089/nat.2023.0050  0.32
2023 Song X, Yu H, Sullenger C, Gray BP, Yan A, Kelly L, Sullenger B. An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway. Cancers. 15. PMID 37190227 DOI: 10.3390/cancers15082301  0.348
2021 Kelly L, Maier KE, Yan A, Levy M. A comparative analysis of cell surface targeting aptamers. Nature Communications. 12: 6275. PMID 34725326 DOI: 10.1038/s41467-021-26463-w  0.581
2018 Yan AC, Levy M. Aptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement. Nucleic Acid Therapeutics. 28: 194-199. PMID 29883295 DOI: 10.1089/Nat.2018.0732  0.555
2016 Kelly L, Kratschmer C, Maier KE, Yan AC, Levy M. Improved Synthesis and In Vitro Evaluation of an Aptamer Ribosomal Toxin Conjugate. Nucleic Acid Therapeutics. PMID 27228412 DOI: 10.1089/Nat.2015.0599  0.513
2015 Kelly L, Maier K, Yan A, Levy M. 144. In Vivo Targeting hTfR and EGFR Using Aptamers Molecular Therapy. 23: S58-S59. DOI: 10.1016/S1525-0016(16)33749-2  0.612
2014 Yan A, Levy M. Cell internalization SELEX: in vitro selection for molecules that internalize into cells. Methods in Molecular Biology (Clifton, N.J.). 1103: 241-65. PMID 24318899 DOI: 10.1007/978-1-62703-730-3_18  0.57
2013 Wilner SE, Wengerter B, Maier K, Magalhães MDLB, Amo DSD, Pai S, Opazo F, Rizzoli SO, Yan A, Levy M. Erratum: An RNA alternative to human transferrin: A new tool for targeting human cells (Molecular Therapy - Nucleic Acids (2013) 2 e79 Doi:10.1038/mtna. 2013.6) Molecular Therapy. Nucleic Acids. 2. PMID 23481355 DOI: 10.1038/Mtna.2013.6  0.552
2012 Wilner SE, Wengerter B, Maier K, de Lourdes Borba Magalhães M, Del Amo DS, Pai S, Opazo F, Rizzoli SO, Yan A, Levy M. An RNA alternative to human transferrin: a new tool for targeting human cells. Molecular Therapy. Nucleic Acids. 1: e21. PMID 23344001 DOI: 10.1038/Mtna.2012.14  0.616
2012 Magalhães ML, Byrom M, Yan A, Kelly L, Li N, Furtado R, Palliser D, Ellington AD, Levy M. A general RNA motif for cellular transfection. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 616-24. PMID 22233578 DOI: 10.1038/Mt.2011.277  0.621
2012 Pastore C, Topalidou I, Forouhar F, Yan AC, Levy M, Hunt JF. Crystal structure and RNA binding properties of the RNA recognition motif (RRM) and AlkB domains in human AlkB homolog 8 (ABH8), an enzyme catalyzing tRNA hypermodification. The Journal of Biological Chemistry. 287: 2130-43. PMID 22065580 DOI: 10.1074/Jbc.M111.286187  0.514
2010 Soriano Del Amo D, Wang W, Jiang H, Besanceney C, Yan AC, Levy M, Liu Y, Marlow FL, Wu P. Biocompatible copper(I) catalysts for in vivo imaging of glycans. Journal of the American Chemical Society. 132: 16893-9. PMID 21062072 DOI: 10.1021/Ja106553E  0.456
2009 Yan AC, Levy M. Aptamers and aptamer targeted delivery. Rna Biology. 6: 316-20. PMID 19458497 DOI: 10.4161/Rna.6.3.8808  0.594
2008 Yan A, Ellington A. A hitchhiker's guide to HIV Molecular Therapy. 16: 1356-1358. PMID 18660800 DOI: 10.1038/Mt.2008.131  0.401
2005 Yan AC, Bell KM, Breeden MM, Ellington AD. Aptamers: prospects in therapeutics and biomedicine. Frontiers in Bioscience : a Journal and Virtual Library. 10: 1802-27. PMID 15769669 DOI: 10.2741/1663  0.527
2002 Yan A, Ellington AD. Aptamers as potential diagnostic reagents for diabetes Diabetes Technology and Therapeutics. 4: 339-346. PMID 12165173 DOI: 10.1089/152091502760098483  0.593
2002 Hartig JS, Najafi-Shoushtari SH, Grüne I, Yan A, Ellington AD, Famulok M. Protein-dependent ribozymes report molecular interactions in real time. Nature Biotechnology. 20: 717-22. PMID 12089558 DOI: 10.1038/Nbt0702-717  0.484
1999 Symensma TL, Baskerville S, Yan A, Ellington AD. Polyvalent Rev Decoys Act as Artificial Rev-Responsive Elements Journal of Virology. 73: 4341-4349. PMID 10196332 DOI: 10.1128/Jvi.73.5.4341-4349.1999  0.502
Show low-probability matches.